Increasing the Clinical Potential and Applications of Anti-HIV Antibodies.

about

HIV Entry and Its Inhibition by Bifunctional Antiviral Proteins

P2860

Q58555325-16087F7E-060F-4147-844C-E705A6835A6F

P2860

Increasing the Clinical Potential and Applications of Anti-HIV Antibodies.

Item

http://www.wikidata.org/entity/Q47110966

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Increasing the Clinical Potential and Applications of Anti-HIV Antibodies.

@en

Increasing the Clinical Potential and Applications of Anti-HIV Antibodies.

@nl

type

Item

label

Increasing the Clinical Potential and Applications of Anti-HIV Antibodies.

@en

Increasing the Clinical Potential and Applications of Anti-HIV Antibodies.

@nl

prefLabel

Increasing the Clinical Potential and Applications of Anti-HIV Antibodies.

@en

Increasing the Clinical Potential and Applications of Anti-HIV Antibodies.

@nl

P1476

Increasing the Clinical Potential and Applications of Anti-HIV Antibodies.

@en

P2093

Casey K Hua

http://www.w3.org/2001/XMLSchema#string

Margaret E Ackerman

http://www.w3.org/2001/XMLSchema#string

P2860

Extensive complement-dependent enhancement of HIV-1 by autologous non-neutralising antibodies at early stages of infection

T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia

ENV-specific cytotoxic T lymphocyte responses in HIV seronegative health care workers occupationally exposed to HIV-contaminated body fluids

Synthetic biology in mammalian cells: next generation research tools and therapeutics

Towards an HIV cure based on targeted killing of infected cells: different approaches against acute versus chronic infection

HIV broadly neutralizing antibody targets

AAV-Delivered Antibody Mediates Significant Protective Effects against SIVmac239 Challenge in the Absence of Neutralizing Activity

Human Non-neutralizing HIV-1 Envelope Monoclonal Antibodies Limit the Number of Founder Viruses during SHIV Mucosal Infection in Rhesus Macaques

Converting monoclonal antibody-based immunotherapies from passive to active: bringing immune complexes into play

Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies

P304

1655

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.3389/FIMMU.2017.01655

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-11-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29234320

http://www.w3.org/2001/XMLSchema#string

P932

5712301

http://www.w3.org/2001/XMLSchema#string

Increasing the Clinical Potential and Applications of Anti-HIV Antibodies.

about

P2860

P2860

Increasing the Clinical Potential and Applications of Anti-HIV Antibodies.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P932